The Tirzepatide (Zepbound) segment is expected to grow at the fastest rate during the forecast period due to its dual-action mechanism, targeting both GLP-1 and GIP receptors, which enhances weight loss outcomes
Laudes M, Oberhauser F, Schulte DM, et al
Hence, chronic oestrogen therapy may protect against obesity and its related comorbidities
Dihydroartemisinin attenuates lipopolysaccharide-induced acute kidney injury by inhibiting inflammation and oxidative stress
A nationwide, population-based cohort study carried out in Denmark including 155 patients with PWS that were followed-up from birth through to first occurrence of an outcome of interest found an increased risk of myocardial infarction, deep venous thrombosis and pulmonary embolisms in these subjects compared to a matched population cohort [32]
This is known as hematuria and should be checked by a doctor